• 1. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026
• 2. Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions
  Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527
• 3. Excited state dynamics of symmetric and asymmetric Cr3(dpa)4Cl2 measured using femtosecond transient absorption spectroscopy?
  Chao-Han Cheng,Wen-Zhen Wang,Shie-Ming Peng,I-Chia Chen Phys. Chem. Chem. Phys., 2017,19, 25471-25477
• 4. Examination of the hydrogen-bonding networks in small water clusters (n = 2–5, 13, 17) using absolutely localized molecular orbital energy decomposition analysis?
  Erika A. Cobar,Paul R. Horn,Robert G. Bergman,Martin Head-Gordon Phys. Chem. Chem. Phys., 2012,14, 15328-15339
• 5. Excitable dynamics in the bromate–sulfite–ferrocyanide reaction
  J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Quinolines and derivatives Haloquinolines

Recent Advances in the Study of 3-Fluoro-6-Methoxy-Quinoline (CAS: 426842-85-5) in Chemical Biology and Pharmaceutical Research

3-Fluoro-6-methoxy-quinoline (CAS: 426842-85-5) has recently emerged as a compound of significant interest in chemical biology and pharmaceutical research due to its versatile applications in drug discovery and development. This heterocyclic compound, characterized by its fluorine and methoxy functional groups, exhibits unique physicochemical properties that make it a promising scaffold for the design of novel therapeutic agents. Recent studies have explored its potential in targeting various biological pathways, including kinase inhibition and antimicrobial activity, highlighting its broad utility in medicinal chemistry.

One of the key areas of research involving 3-fluoro-6-methoxy-quinoline is its role as a kinase inhibitor. Kinases are critical enzymes involved in signal transduction and are often dysregulated in diseases such as cancer and inflammatory disorders. A 2023 study published in the Journal of Medicinal Chemistry demonstrated that derivatives of 3-fluoro-6-methoxy-quinoline exhibit potent inhibitory activity against specific tyrosine kinases, with IC50 values in the nanomolar range. The study utilized structure-activity relationship (SAR) analysis to optimize the compound's binding affinity and selectivity, paving the way for the development of next-generation kinase inhibitors.

In addition to its kinase inhibitory properties, 3-fluoro-6-methoxy-quinoline has shown promise as an antimicrobial agent. A recent publication in Bioorganic & Medicinal Chemistry Letters reported that this compound exhibits broad-spectrum activity against both Gram-positive and Gram-negative bacteria, including drug-resistant strains such as MRSA. The mechanism of action appears to involve disruption of bacterial cell membrane integrity, as evidenced by electron microscopy and fluorescence-based assays. These findings suggest that 3-fluoro-6-methoxy-quinoline could serve as a lead compound for the development of new antibiotics to address the growing threat of antimicrobial resistance.

Another notable application of 3-fluoro-6-methoxy-quinoline is in the field of fluorescence imaging. Due to its intrinsic fluorescent properties, this compound has been employed as a molecular probe for studying cellular processes. A 2022 study in Chemical Communications detailed the synthesis of a 3-fluoro-6-methoxy-quinoline-based probe for real-time imaging of lysosomal pH dynamics in live cells. The probe demonstrated high photostability and sensitivity, making it a valuable tool for biomedical research and diagnostics.

The synthetic accessibility of 3-fluoro-6-methoxy-quinoline has also been a focus of recent research. A team of chemists recently developed a novel one-pot synthesis method for this compound, as described in Organic Letters. The method employs a palladium-catalyzed coupling reaction, offering improved yield and scalability compared to traditional approaches. This advancement is expected to facilitate the broader adoption of 3-fluoro-6-methoxy-quinoline in both academic and industrial settings.

In conclusion, 3-fluoro-6-methoxy-quinoline (CAS: 426842-85-5) represents a multifaceted compound with significant potential in drug discovery, antimicrobial therapy, and molecular imaging. Ongoing research continues to uncover new applications and optimize its properties, positioning it as a valuable asset in the toolbox of medicinal chemists and biologists. Future studies are likely to explore its utility in additional therapeutic areas and further refine its pharmacological profile.

• 643032-47-7(Acridine, 1,2,3,4-tetrafluoro-7-phenoxy-)
• 120651-13-0(Acridine, 1,2,3,4-tetrafluoro-7-methoxy-)
• 142363-59-5(3-fluoroquinolin-8-ol)
• 887769-90-6(5-fluoro-7-methoxy-Quinoline)
• 61293-17-2(6-Fluoro-4-methoxyquinoline)
• 288384-55-4(3-fluoroquinolin-7-ol)
• 808755-53-5(3-fluoroquinolin-6-ol)
• 887769-93-9(8-fluoro-5-methoxy-Quinoline)
• 209353-21-9(8-Fluoro-6-methoxyquinoline)
• 1261729-67-2(3-Fluoroquinolin-5-OL)